{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:50:09Z","timestamp":1789973409150,"version":"4.0.1"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,13]]},"DOI":"10.18632\/oncotarget.12824","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T09:04:16Z","timestamp":1477127056000},"page":"82985-83000","source":"Crossref","is-referenced-by-count":13,"title":["A new humanized\n                    <i>in vivo<\/i>\n                    model of\n                    <i>KIT<\/i>\n                    D816V+ advanced systemic mastocytosis monitored using a secreted luciferase"],"prefix":"10.18632","volume":"7","author":[{"given":"Siham","family":"Bibi","sequence":"first","affiliation":[{"name":"Molecular and Cellular Oncology Research Group, LBPA CNRS UMR 8113, Ecole Normale Sup\u00e9rieure de Cachan, Cachan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"INSERM Unit U1170, H\u00e9matopo\u00ef\u00e8se normale et pathologique, Gustave Roussy Campus, Universit\u00e9 Paris Sud Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hugonin","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Oncology Research Group, LBPA CNRS UMR 8113, Ecole Normale Sup\u00e9rieure de Cachan, Cachan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallorie Depond","family":"Mangean","sequence":"additional","affiliation":[{"name":"INSERM Unit U1170, H\u00e9matopo\u00ef\u00e8se normale et pathologique, Gustave Roussy Campus, Universit\u00e9 Paris Sud Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"He","sequence":"additional","affiliation":[{"name":"INSERM Unit U1170, H\u00e9matopo\u00ef\u00e8se normale et pathologique, Gustave Roussy Campus, Universit\u00e9 Paris Sud Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaith","family":"Wedeh","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Oncology Research Group, LBPA CNRS UMR 8113, Ecole Normale Sup\u00e9rieure de Cachan, Cachan, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Launay","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie et Biologie Mol\u00e9culaire, Inserm U942, H\u00f4pital Lariboisi\u00e8re, AP-HP, Universit\u00e9 Paris Diderot - Paris VII Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Van Rijn","sequence":"additional","affiliation":[{"name":"Neuro-oncology Research Group, Department of Neurosurgery, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"W\u00fcrdinger","sequence":"additional","affiliation":[{"name":"Neuro-oncology Research Group, Department of Neurosurgery, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherland"},{"name":"Neuroscience Center, Department of Neurology, Massachussetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzia","family":"Louache","sequence":"additional","affiliation":[{"name":"INSERM Unit U1170, H\u00e9matopo\u00ef\u00e8se normale et pathologique, Gustave Roussy Campus, Universit\u00e9 Paris Sud Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Arock","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Oncology Research Group, LBPA CNRS UMR 8113, Ecole Normale Sup\u00e9rieure de Cachan, Cachan, France"},{"name":"Laboratoire Central d'H\u00e9matologie, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP, Universit\u00e9 Pierre et Marie Curie (UPMC) Paris VI, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Metcalfe","year":"1991","journal-title":"J Immunol"},{"key":"2","first-page":"13","article-title":"The human mast cell: an overview","volume":"315","author":"Chi","year":"2006","journal-title":"Methods Mol Biol"},{"key":"3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Hunter","year":"2001","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000236928","article-title":"Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor","volume":"107","author":"Costa","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.iac.2006.05.004","article-title":"Molecular mechanisms of mast cell development","volume":"26","author":"Ito","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.iac.2013.09.001","article-title":"Mastocytosis","volume":"34","author":"Komarow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1309\/AJCPPXHMN5CJOXHZ","article-title":"Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells","volume":"132","author":"Horny","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Valent","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"9","first-page":"399","article-title":"Systemic mastocytosis","volume":"142","author":"Valent","year":"2008","journal-title":"Cancer Treat Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/ehm.10.42","article-title":"Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives","volume":"3","author":"Valent","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Brunning","year":"2001","journal-title":"Leuk Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2011.192","article-title":"Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and\/or CD2' WHO criterion","volume":"25","author":"Escribano","year":"2012","journal-title":"Mod Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Metcalfe","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Gotlib","year":"2015","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"17","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdu047","article-title":"Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal","volume":"25","author":"Hornick","year":"2014","journal-title":"Ann Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.iac.2014.01.009","article-title":"Molecular defects in mastocytosis: KIT and beyond KIT","volume":"34","author":"Arock","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Longley","year":"2002","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2005-07-3022","article-title":"PKC412 inhibitsgrowth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects","volume":"107","author":"Valent","year":"2006","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis","volume":"374","author":"Stanek","year":"2016","journal-title":"N Engl J Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation","volume":"202","author":"Liblau","year":"2005","journal-title":"J Exp Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit","volume":"117","author":"Roers","year":"2011","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-1281(98)80002-0","article-title":"Lectin histochemistry of human leukaemic mast cells (HMC-1) transplanted into severe combined immunodeficient (scid) mice","volume":"100","author":"Mitchell","year":"1998","journal-title":"Acta Histochem"},{"key":"25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.exphem.2005.11.015","article-title":"Establishment of a murine model of aggressive systemic mastocytosis\/mast cell leukemia","volume":"34","author":"Deininger","year":"2006","journal-title":"Exp Hematol"},{"key":"26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2013-10-534685","article-title":"A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection","volume":"124","author":"Nguyen-Khac","year":"2014","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nmeth.1177","article-title":"A secreted luciferase for ex vivo monitoring ofprocesses","volume":"5","author":"Tannous","year":"2008","journal-title":"Nat Methods"},{"key":"28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood-2010-05-285270","article-title":"The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)","volume":"116","author":"Horny","year":"2010","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000048182","article-title":"Mastocytosis and fibrosis: role of cytokines","volume":"127","author":"Baek","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"30","first-page":"737302","article-title":"Serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant)","volume":"2015","author":"Stefanini","year":"2015","journal-title":"Case Rep Hematol"},{"key":"31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy","volume":"99","author":"Arock","year":"2014","journal-title":"Haematologica"},{"key":"32","first-page":"1115","article-title":"Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Ashman","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Escribano","year":"2007","journal-title":"Br J Haematol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications","volume":"28","author":"Orfao","year":"2015","journal-title":"Mod Pathol"},{"key":"35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/srep01046","article-title":"Functional multiplex reporter assay using tagged Gaussia luciferase","volume":"3","author":"Wurdinger","year":"2013","journal-title":"Sci Rep"},{"key":"36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.tibtech.2011.06.010","article-title":"Bioluminescence imaging: progress and applications","volume":"29","author":"Tannous","year":"2011","journal-title":"Trends Biotechnol"},{"key":"37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000315946","article-title":"Mastocytosis","volume":"95","author":"Metcalfe","year":"2010","journal-title":"Chem Immunol Allergy"},{"key":"38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2010.11.014","article-title":"Early relapse in ALL is identified by time to leukemia in NOD\/SCID mice and is characterized by a gene signature involving survival pathways","volume":"19","author":"Zimmermann","year":"2011","journal-title":"Cancer Cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Gleich","year":"1988","journal-title":"Leuk Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay","volume":"13","author":"Moller","year":"2011","journal-title":"J Mol Diagn"},{"key":"42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mt.2012.38","article-title":"A water-soluble coelenterazine for sensitiveimaging of coelenterate luciferases","volume":"20","author":"Tannous","year":"2012","journal-title":"Mol Ther"},{"key":"43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01533368","article-title":"Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis","volume":"14","author":"Van der Linden","year":"1994","journal-title":"J Clin Immunol"},{"key":"44","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Schwartz","year":"2001","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T11:36:56Z","timestamp":1692531416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":44,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12,13]]}},"alternative-id":["12824","27783996"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12824","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,22]]}}}